Med. praxi. 2019;16(1):20-22 | DOI: 10.36290/med.2019.046

Hepatoprotectives and their use in general practice

doc. MUDr. Bohumil Seifert, Ph.D.
Ústav všeobecného lékařství 1. LF UK, Praha

Hepatoprotectives are a large group of natural compounds with a presumed positive, protective, and regenerative effect on the liver cell. They are characterized by very good tolerance and safety profile, corroborated by thousands of years of use. The efficacy of some hepatoprotectives, such as silymarin or vitamin E, is well evidenced in the literature. The efficacy and role of other potentially hepatoprotective agents have been the subject of medical research all over the world. In modern hepatology, primarily aimed at effective causal treatment of chronic hepatitides and other clinical entities, the position of hepatoprotectives is weakened. In the general practice setting where the general practitioner (GP) encounters patients with various stages of liver disease, the situation is different. The GP is in charge of the care of individuals with varied lifestyles, chronic medication, metabolic syndrome, overweight, or type 2 diabetes. These patients have a high prevalence of hepatic disorders, steatosis, and steatohepatitis, i.e. diseases with a potentially progressive course for which there is no simple therapeutic solution. In these patients, drugs from the field of complementary and alternative medicine can be a useful part of comprehensive approaches, as is the case with hepatoprotectives.

Keywords: hepatoprotectives, liver disease, NAFLD, silymarin, vitamin E, caffeine

Received: February 27, 2017; Accepted: April 10, 2017; Published: February 25, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Seifert B. Hepatoprotectives and their use in general practice. Med. praxi. 2019;16(1):20-22. doi: 10.36290/med.2019.046.
Download citation

References

  1. Ghosh N, Ghosh R, Mandal V, Mandal SC. Recent advances in herbal medicine for treatment of liver disease (Review). Pharmaceutical Biology 2011; 49(9): 970-988. Go to original source... Go to PubMed...
  2. www.svod.cz
  3. Urbánek P, Seifert B. Abnormální jaterní testy. Suplementum, Doporučený postup pro praktické lékaře, SVL ČLS JEP 2018.
  4. Ferramosca A, Di Giacomo M, Zara V. Antioxidant dietary approach in treatment of fatty liver. New insights und updates (Review) World Journal of Gastroenterology 2017; 23(23): 4146-4157. Go to original source... Go to PubMed...
  5. Singh S, Osna NA, Kharbanda KK. Treatment options for alcoholic and non-alcoholic fatty liver disease: A review. World Journal of gastroenterology 2017; 23(36): 6549-6570. Go to original source... Go to PubMed...
  6. Seeff LB, Lindsay KL, Bacon BR, Kresina TF, Hoofnagle JH. Complementary and Alternative Medicine in Chronic Liver Disease, Hepatology 2001; 34(3). Go to original source... Go to PubMed...
  7. Bahmani M, Shirtzad H, Rafieian S, Rafieian-Kopaei M. Silybum marianum: Beyond Hepatoprotection, Journal of Evidence-Based Complementary & Alternative Medicine 2015; 20(4): 292-301. Go to original source... Go to PubMed...
  8. Abenavoli, Milic N. Silymarin for Liver disease in Therapies and antioxidants, in Liver Pathofysiology, 2017: 621-631. Go to original source...
  9. Karimi G, Vahabzadeh M, Lari P, Moshiri M. "Silymarin", a Promising Pharmacological Agent for Treatment of Diseases, Iran J Basic Med Sci, 2011; 14(4): 308-317.
  10. Galli F, Azzi A, Birringer M, et al. Vitamin E: Emerging Aspects and new directions. Free Radical Bilogy & Medicine 2017; 102: 16-36. Dostupné z: https://www.ncbi.nlm.nih.gov/pubmed/?term=Rashedinia%20M%5BAuthor%5D&cauthor=true&cauthor_uid=23492971 Go to original source... Go to PubMed...
  11. Szantová M, Durkovicova Z. Káva ako hepatoprotektivny factor, Vnitřní lékařství 2016; 62(12): 990-997. Go to PubMed...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.